Different from their findings, we suggest that these genes, along with OASL, RSAD2, ISG20, IFI16, IFIT1, CX3CR1, IFIT3, IRF7, and IFI27, had rapidly decreased expression in the severe COVID-19 patients and lower expression than in the mild disease patients. This evidence concerns the gene IFIT3 and COVID-19.